We have observed
25 EP applications
Michael Antony Reed
has served for within the last five+ years.
(We consider all applications which have an EP A1 or A2 publication dated after November 16, 2013).
Please note, that we only count EP applications,
in which the name of the patent attorney is explicitly mentioned as representative.
These EP applications are:
DIHYDROPYRROLO PYRIMIDINE DERIVATIVES AS MTOR INHIBITORS
FATTY ACID SYNTHASE INHIBITORS
METHOD OF TREATMENT
METHOD OF TREATING CANCER
METHOD OF ADMINISTRATION AND TREATMENT
TREATMENT METHOD FOR STEROID RESPONSIVE DERMATOSES
Pyridazine-dione N-substituted glycine derivatives as HIF hydroxylase inhibitors
ENHANCER OF ZESTE HOMOLOG 2 INHIBITORS
CHEMICAL COMPOUNDS ACTING AS PERK INHIBITORS
NAPHTHYRIDINE DERIVATIVES AS ALPHA V BETA 6 INTEGRIN ANTAGONISTS FOR THE TREATMENT OF E.G. FIBROTIC DISEASES